EPZ020411

CAS No. 1700663-41-7

EPZ020411( EPZ-020411 )

Catalog No. M12596 CAS No. 1700663-41-7

EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 212 In Stock
10MG 353 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EPZ020411
  • Note
    Research use only, not for human use.
  • Brief Description
    EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM.
  • Description
    EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM, displays 10-fold and 20-fold selectivity over PRMT1/8, and >100-fold over other histone methyltransferases (PRMT3/4/5/7); dose-dependently decreases H3R2 methylation A375 cell line with IC50 of 0.637 uM, with no affect levels of PRMT6 expression; exhibits good bioavailability following subcutaneous dosing in rats making it a suitable tool for potential in vivo target validation studies.
  • In Vitro
    EPZ020411 (0-20 μM; 24 h) decreases H3R2 methylation in A375 cells.EPZ020411 (20-40 μM; 6 h) reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival. Western Blot Analysis Cell Line:A375 cells Concentration:0-20 μM Incubation Time:24 hours Result:Dose-dependently decreased H3R2 methylation in A375 cells with an IC50 of 0.634 μM.Apoptosis Analysis Cell Line:Cultured cochleae cells Concentration:20-40 μM Incubation Time:6 hours Result:Suppressed the apoptotic cascade induced by aminoglycosides and also inhibited cisplatin-induced apoptosis in the hair cells of the cochlear explants after pretreatment deposed. Also reduced hair cell loss caused by cisplatin treatment.
  • In Vivo
    EPZ020411 (10 mg/kg; i.p. once) reduces neomycin- and cisplatin-induced hearing loss in C57BL/6J wild-type mice with acute ototoxicity model.Pharmacokinetic Parameters of EPZ020411 in rats. Animal Model:C57BL/6J wild-type mice at P28 with acute ototoxicity model Dosage:10 mg/kg Administration:Intraperitoneal injection; 10 mg/kg once Result:Significantly reduced neomycin- and cisplatin-induced HC loss and showed no effect without neomycin injection with mice.
  • Synonyms
    EPZ-020411
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    PRMT6
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1700663-41-7
  • Formula Weight
    442.5942
  • Molecular Formula
    C25H38N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CNCCN(C)CC1=C(NN=C1)C2=CC=C(C=C2)OC3CC(C3)OCCC4CCOCC4
  • Chemical Name
    1,2-Ethanediamine, N1,N2-dimethyl-N1-[[3-[4-[[trans-3-[2-(tetrahydro-2H-pyran-4-yl)ethoxy]cyclobutyl]oxy]phenyl]-1H-pyrazol-4-yl]methyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mitchell LH, et al. ACS Med Chem Lett. 2015 Apr 6;6(6):655-9.
molnova catalog
related products
  • MI-503

    A highly potent and orally bioavailable small-molecule inhibitor of Menin-MLL interaction with Kd of 9.3 nM.

  • EPZ 025654

    EPZ025654 (GSK 35336023) is a potent, selective arginine methyltransferase CARM1 inhibitor with IC50 of 3 nM.

  • EPZ004777 HCl

    EPZ004777 hydrochloride is a potent, selective DOT1L inhibitor with IC50 of 0.4 nM.